Department of Chemistry "Ugo Schiff", University of Florence and CSGI, Florence, Italy.
IMRCP, UMR5623 CNRS, Université de Toulouse, Toulouse, France.
Colloids Surf B Biointerfaces. 2022 Dec;220:112884. doi: 10.1016/j.colsurfb.2022.112884. Epub 2022 Sep 27.
The design of drug delivery systems (DDS) for the encapsulation of therapeutic agents and the controlled release to the target site of the disease is one of the main goals of nanomedicine. Although already explored in an extensive number of studies over the years, lipid assemblies, and particularly liposomes, are still considered the most promising and interesting candidates as DDS due to their biocompatibility and structural similarity with plasma membranes. Lately, this research area has been extended to include more complex lipid assemblies, such as cubosomes. Cubosomes are an emerging structural platform for the delivery of molecules with pharmaceutical interest, such as drugs, bioactives and contrast agents. Here we report on the application of a thermo-responsive copolymer poly(N,N-dimethylacrylamide)-block-poly(N-isopropylacrylamide) (PDMA-b-PNIPAM), as a thermoresponsive stabilizer of lipid-based nanoparticles for drug-delivery. First, we assessed the affinity of PDMA-b-PNIPAM towards supported and free-standing bilayers; then, we explored the colloidal and thermoresponsive properties of cubic self-assembled DDS composed of glycerol-monooleate (GMO), where PDMA-b-PNIPAM replaces the conventional stabilizer Pluronic F127 (PEOx-PPOy-PEOx), normally used for cubosomes. We prepared dispersions of cubic lipid nanoparticles with two PDMA-b-PNIPAM block copolymers of different molar mass. The colloidal properties were then assessed and compared to those exhibited by standard lipid cubic dispersions stabilized by Pluronic F-127, combining a series of experimental techniques (Quartz Crystal Microbalance with Dissipation monitoring, Dynamic Light Scattering, Small-Angle X-rays Scattering, Cryo-Transmission Electron Microscopy). Interestingly, PDMA-b-PNIPAM stabilized cubosomes display additional benefits with respect to those stabilized by Pluronic, thanks to the combination of a "sponge " effect for the controlled release of encapsulated molecules and an increased affinity towards lipid bilayer membranes, which is a promising feature to maximize fusion with the target-cellular site.
药物传递系统(DDS)的设计用于封装治疗剂并将其控释到疾病的靶部位是纳米医学的主要目标之一。尽管多年来已经在大量研究中进行了探索,但由于其生物相容性和与质膜的结构相似性,脂质组装体,特别是脂质体,仍然被认为是最有前途和最有趣的 DDS 候选物。最近,这个研究领域已经扩展到包括更复杂的脂质组装体,如立方脂质体。立方脂质体是一种新兴的分子传递结构平台,具有药物、生物活性物质和对比剂等药物的应用潜力。在这里,我们报告了一种温敏共聚物聚(N,N-二甲基丙烯酰胺)-嵌段-聚(N-异丙基丙烯酰胺)(PDMA-b-PNIPAM)作为一种用于药物传递的基于脂质的纳米粒子的温敏稳定剂的应用。首先,我们评估了 PDMA-b-PNIPAM 对支撑和独立双层膜的亲和力;然后,我们探索了由甘油单油酸酯(GMO)组成的立方自组装 DDS 的胶体和温敏性质,其中 PDMA-b-PNIPAM 取代了通常用于立方脂质体的常规稳定剂泊洛沙姆 F127(PEOx-PPOy-PEOx)。我们用两种不同摩尔质量的 PDMA-b-PNIPAM 嵌段共聚物制备了立方脂质纳米粒子的分散体。然后评估胶体性质,并将其与泊洛沙姆 F-127 稳定的标准立方脂质分散体的性质进行比较,结合了一系列实验技术(石英晶体微天平监测耗散、动态光散射、小角 X 射线散射、冷冻透射电子显微镜)。有趣的是,与泊洛沙姆稳定的立方脂质体相比,PDMA-b-PNIPAM 稳定的立方脂质体具有额外的优势,这要归功于“海绵”效应的控制释放包封分子和增加的亲脂双层膜的亲和力,这是一个很有前途的特征,以最大限度地与靶细胞部位融合。